HNRNPA1L2 Activators
HNRNPA1L2 Activators belong to a class of chemical compounds that specifically target and modulate the activity of the heterogeneous nuclear ribonucleoprotein A1-like 2 (HNRNPA1L2) protein. HNRNPA1L2 is a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) family, which plays a crucial role in post-transcriptional gene regulation and RNA processing. These activators are designed to influence the function of HNRNPA1L2 by interacting with its molecular structure, ultimately leading to alterations in its RNA-binding properties and downstream effects on gene expression and RNA metabolism.
HNRNPA1L2 Activators typically work by binding to specific sites on the HNRNPA1L2 protein, inducing conformational changes that can affect its interactions with RNA molecules. This modulation of HNRNPA1L2's activity can impact various cellular processes, including alternative splicing, mRNA stability, and RNA transport. By altering these fundamental processes, HNRNPA1L2 Activators have the potential to influence gene expression patterns and cellular responses in a highly specific and controlled manner.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $39.00 $75.00 | 9 | |
ATP is an energy molecule that indirectly supports RNA metabolism by providing the energy required for various cellular processes, including transcription and splicing. Increased ATP levels can enhance overall cellular activity, which could indirectly increase HNRNPA1L2 activity by ensuring that essential cellular processes, such as RNA splicing, proceed efficiently. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Spliceostatin A inhibits the spliceosome, affecting splicing processes directly. While it primarily disrupts splicing, its inhibition of splicing may indirectly increase HNRNPA1L2 activity by altering the pool of spliced RNA substrates that HNRNPA1L2 interacts with. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin inhibits both transcription and translation processes. Its impact on transcription may indirectly activating HNRNPA1L2 by reducing the production of pre-mRNA substrates, while its effect on translation may affect the availability of RNA molecules for processing by HNRNPA1L2. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-FU is incorporated into RNA, disrupting its function. The incorporation of 5-FU into RNA molecules can directly activating HNRNPA1L2 by altering the structure or stability of RNA substrates that it interacts with during splicing. | ||||||